Companies · Other Health Care

Orthosensor, Inc

DANIA BEACH · Other Health Care

Diligence memoA one-page analyst read on Orthosensor, Inc — recommendation, valuation, rhythm, risks.
$112.8M
Total raised · real
15
Rounds
0.2×
Latest step-up
Top 5%
Sector rank · raised
Recurring offerings
Latest stage · inferred · Fri Oct 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

Orthosensor, Inc has raised $113M over 15 rounds; too few niche peers to rank its valuation yet.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Program ended
  • Last raise 5.7 yr ago; this sector typically re-raises about every 14 months.
  • For a recurring offering issuer, long silence usually means the offering program is inactive or ended; it is not proof the legal entity is defunct.

Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.

Recurring offering issuermedium confidence

Orthosensor, Inc behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.

Issuer structure
Program-like
Frequent filings and follow-ons read more like a securities offering program than discrete startup rounds.
Lifecycle
16.0 yr record
Peak capital year was 2018 with $83.4M across 13 filings.
Market position
ahead of 96% of Other Health Care peers
Capital scale is ahead of 96% of Other Health Care peers; modeled value is above 57% of peers by modeled value. Large capital with mid-pack modeled value can signal an issuer/program profile rather than operating-company growth.
Valuation reliability
Lower applicability
Stage/dilution valuation models are weakest when the issuer is broad-sector, recurring, or vehicle-like.
Operating evidence
Sparse
No clear CEO/founder/principal role is surfaced, so operating-company confidence is lower.
Data quality
Needs review
Row-level filing totals differ from canonical totals, so amendment/superseded filtering should be checked.
What triggered this
  • 33 dated financing filings, averaging about 4 months apart.
  • No clearly named CEO/founder/principal role in the public records surfaced here.
  • No verified homepage on the profile yet.
  • Capital program peaked in 2018: $83.4M across 13 filings.
  • Largest single filing was $29.1M on 2010-12-03.
  • Filing rows sum to $208.1M, while canonical raised total is $112.8M; likely amendments/superseded rows are mixed into the detail view.
How to read the page
  • Read this less like a startup funding journey and more like a capital-raising program.
  • Stage-based valuation and peer labels have lower applicability for this pattern.
  • The more important signal is lifecycle: repeated filings ended years ago, so current activity needs outside confirmation.
  • Canonical filtering should be tightened before using row-level totals for diligence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

Orthosensor, Inc is one of 5377 Other Health Care companies tracked from DANIA BEACH. By capital raised it ranks among the largest (ahead of 96% of sector peers), and mid-pack by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
1
Investors (latest)
2020-10-30
First sale
Amount raised vs valuation, by year

This issuer has a dense recurring filing history, so the chart groups filings by year. Solid bars are annual reported capital reported; hatched bars show the latest modeled value est. observed in that year. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Annual capital raised · realLatest value in year · estCumulative funded · real

Dense history compressed: 33 filings shown as 9 yearly buckets. Hover a bucket for filing count, annual capital, and latest modeled value.

$0$125M$250M$375M$500M2010: 3 filings Raised $32M total (real) Latest modeled valuation $13M (est)20103 filings2013: 2 filings Raised $23M total (real) Latest modeled valuation $266M (est)20132 filings2014: 2 filings Raised $29M total (real) Latest modeled valuation $375M (est)20142 filings2015: 1 filing Raised $3.9M total (real) Latest modeled valuation $86M (est)20151 filings2016: 4 filings Raised $5.3M total (real) Latest modeled valuation $30M (est)20164 filings2017: 3 filings Raised $14M total (real) Latest modeled valuation $140M (est)20173 filings2018: 13 filings Raised $83M total (real) Latest modeled valuation $359M (est)201813 filings2019: 2 filings Raised $7.3M total (real) Latest modeled valuation $139M (est)20192 filings2020: 3 filings Raised $9.3M total (real) Latest modeled valuation $30M (est)20203 filings+$23M+$29M+$3.9M+$5.3M+$14M+$83M+$7.3M+$9.3MCumulative $208M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps

This looks like a recurring offering series, so a VC stage ladder would be misleading. Showing the filed offering sequence instead.

Initial offering$3.0M · 2010
Follow-on offering$29.1M · 2010
Follow-on offering$415K · 2010
Follow-on offering$11.4M · 2013
Follow-on offering$12.0M · 2013
Follow-on offering$12.0M · 2014
Follow-on offering$16.9M · 2014
Follow-on offering$3.9M · 2015
Follow-on offering$208K · 2016
Follow-on offering$1.8M · 2016
Follow-on offering$2.4M · 2016
Follow-on offering$972K · 2016
Follow-on offering$4.9M · 2017
Follow-on offering$3.0M · 2017
Follow-on offering$6.3M · 2017
Follow-on offering$2.8M · 2018
Follow-on offering$2.0M · 2018
Follow-on offering$5.2M · 2018
Follow-on offering$4.1M · 2018
Follow-on offering$6.0M · 2018
Follow-on offering$2.5M · 2018
Follow-on offering$4.7M · 2018
Follow-on offering$12.2M · 2018
Follow-on offering$8.3M · 2018

Showing first 24 of 33 filings to keep the sequence readable.

Modeled valuation trajectory
$30.0M
Base estimate est.
$3.5M
Conservative case
$108.6M
Upside case
$8.3M
Modeled post-money

This issuer files recurring offerings, so the model treats stage labels as a loose sizing heuristic, not a clean VC ladder. The estimate anchors on reported filing amounts and dates, then applies benchmark dilution, survival, and markup assumptions. Directional, not a quoted figure.

Seed · modeled $74.4M · 2010-07-012010Series B · modeled $643.6M · 2010-12-03Pre-Seed · modeled $12.8M · 2010-12-03Series A · modeled $229.6M · 2013-03-28Series B · modeled $265.9M · 2013-03-28Series B · modeled $265.9M · 2014-07-01Series B · modeled $374.7M · 2014-11-10Series B · modeled $85.9M · 2015-11-24Pre-Seed · modeled $6.4M · 2016-04-29Seed · modeled $44.8M · 2016-04-29Series B · modeled $52.1M · 2016-04-29Pre-Seed · modeled $30.0M · 2016-04-29Series A · modeled $98.0M · 2017-04-10Seed · modeled $74.9M · 2017-04-10Series B · modeled $139.7M · 2017-04-10Series B · modeled $61.5M · 2018-01-26Seed · modeled $49.6M · 2018-01-26Series B · modeled $115.2M · 2018-05-02Series A · modeled $82.7M · 2018-05-02Series B · modeled $132.7M · 2018-08-10Seed · modeled $62.0M · 2018-08-10Series A · modeled $95.3M · 2018-08-10Series A · modeled $245.5M · 2018-11-16Series A · modeled $168.0M · 2018-11-16Seed · modeled $82.4M · 2018-11-16Series B · modeled $216.0M · 2018-11-16Series A · modeled $127.6M · 2018-11-16Series B · modeled $358.6M · 2018-11-16Pre-Seed · modeled $30.8M · 2019-05-02Series B · modeled $139.1M · 2019-05-02Series B · modeled $26.5M · 2020-10-09Series B · modeled $131.9M · 2020-10-15Series B · modeled $30.0M · 2020-10-302020
Model inputs · modeled:benchmark-stage-stepup-v1
18%
Dilution assumption
Implied ownership sold in the financing.
64%
Survival probability
42% low · 78% high
1.36×/yr
Annual markup
1.64×/yr upside case
5.7 yr
Elapsed time used
5.7 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
4 mo
Avg between rounds
$10.9M/yr
Capital velocity
16.0 yr
On record since
2010
First round
33
Rounds on file
How it compares to the market

Benchmarked against 5377 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 46× above median
This company$112.8M
Sector median$2.4M
Modeled value — vs sector median (estimate, all stages) 1.4× above median
This company$30.0M
Sector median$22.1M

Raised more than 96% of sector peers (real $). Modeled value above 57% of peers (estimate).

Full financing history

This issuer files too frequently for VC stage labels to be meaningful, so rows are shown as initial/follow-on offerings est. instead of Pre-Seed/Seed/Series buckets.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Initial offering$3.0M2010-07-01$15.0M$74.4M85%
Follow-on offering$29.1M2010-12-03$161.4M$643.6M85%
Follow-on offering$415K2010-12-03$2.3M$12.8M85%
Follow-on offering$11.4M2013-03-28$51.7M$229.6M85%
Follow-on offering$12.0M2013-03-28$66.7M$265.9M85%
Follow-on offering$12.0M2014-07-01$66.7M$265.9M85%
Follow-on offering$16.9M2014-11-10$94.0M$374.7M85%
Follow-on offering$3.9M2015-11-24$21.5M$85.9M85%
Follow-on offering$208K2016-04-29$1.2M$6.4M85%
Follow-on offering$1.8M2016-04-29$9.0M$44.8M90%
Follow-on offering$2.4M2016-04-29$13.1M$52.1M90%
Follow-on offering$972K2016-04-29$5.4M$30.0M85%
Follow-on offering$4.9M2017-04-10$22.1M$98.0M90%
Follow-on offering$3.0M2017-04-10$15.1M$74.9M90%
Follow-on offering$6.3M2017-04-10$35.0M$139.7M90%
Follow-on offering$2.8M2018-01-26$15.4M$61.5M90%
Follow-on offering$2.0M2018-01-26$10.0M$49.6M90%
Follow-on offering$5.2M2018-05-02$28.9M$115.2M90%
Follow-on offering$4.1M2018-05-02$18.6M$82.7M90%
Follow-on offering$6.0M2018-08-10$33.3M$132.7M90%
Follow-on offering$2.5M2018-08-10$12.5M$62.0M90%
Follow-on offering$4.7M2018-08-10$21.5M$95.3M90%
Follow-on offering$12.2M2018-11-16$55.3M$245.5M90%
Follow-on offering$8.3M2018-11-16$37.8M$168.0M90%
Follow-on offering$3.3M2018-11-16$16.6M$82.4M90%
Follow-on offering$9.8M2018-11-16$54.2M$216.0M90%
Follow-on offering$6.3M2018-11-16$28.7M$127.6M90%
Follow-on offering$16.2M2018-11-16$89.9M$358.6M90%
Follow-on offering$1.0M2019-05-02$5.6M$30.8M90%
Follow-on offering$6.3M2019-05-02$34.9M$139.1M90%
Follow-on offering$1.3M2020-10-09$7.2M$26.5M90%
Follow-on offering$6.5M2020-10-15$36.1M$131.9M90%
Follow-on offering$1.5M2020-10-30$8.3M$30.0M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Initial offering$3.0M2010-07-01
    • First recorded raise — entered as Initial offering.
  2. Follow-on offering$29.1M2010-12-03
    • Came back fast: 5 mo vs the ~14 mo sector norm.
    • Round 9.7× larger than the prior — scaling up.
    • 81 investors on this round.
  3. Follow-on offering$415K2010-12-03
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 70.1× smaller than the prior — bridge or down round.
    • 4 investors on this round.
  4. Follow-on offering$11.4M2013-03-28
    • Raised again after 28 mo — slower than the ~14 mo sector norm.
    • Round 27.4× larger than the prior — scaling up.
    • 34 investors on this round.
  5. Follow-on offering$12.0M2013-03-28
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
    • Switched to Rule 506(b) (was Rule 06).
    • 39 investors on this round.
  6. Follow-on offering$12.0M2014-07-01
    • Raised 15 mo later, in step with the ~14 mo sector norm.
    • Round roughly the size of the prior one.
  7. Follow-on offering$16.9M2014-11-10
    • Came back fast: 4 mo vs the ~14 mo sector norm.
    • Round 1.4× larger than the prior — scaling up.
    • 32 investors on this round.
  8. Follow-on offering$3.9M2015-11-24
    • Raised 12 mo later, in step with the ~14 mo sector norm.
    • Round 4.4× smaller than the prior — bridge or down round.
    • 9 investors on this round.
  9. Follow-on offering$208K2016-04-29
    • Came back fast: 5 mo vs the ~14 mo sector norm.
    • Round 18.7× smaller than the prior — bridge or down round.
    • 1 investor on this round.
  10. Follow-on offering$1.8M2016-04-29
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 8.7× larger than the prior — scaling up.
    • 7 investors on this round.
  11. Follow-on offering$2.4M2016-04-29
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.3× larger than the prior — scaling up.
    • 11 investors on this round.
  12. Follow-on offering$972K2016-04-29
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 2.4× smaller than the prior — bridge or down round.
    • 6 investors on this round.
  13. Follow-on offering$4.9M2017-04-10
    • Raised 11 mo later, in step with the ~14 mo sector norm.
    • Round 5.0× larger than the prior — scaling up.
    • 14 investors on this round.
  14. Follow-on offering$3.0M2017-04-10
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.6× smaller than the prior — bridge or down round.
    • 7 investors on this round.
  15. Follow-on offering$6.3M2017-04-10
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 2.1× larger than the prior — scaling up.
    • 15 investors on this round.
  16. Follow-on offering$2.8M2018-01-26
    • Raised 10 mo later, in step with the ~14 mo sector norm.
    • Round 2.3× smaller than the prior — bridge or down round.
    • 4 investors on this round.
  17. Follow-on offering$2.0M2018-01-26
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.4× smaller than the prior — bridge or down round.
    • 1 investor on this round.
  18. Follow-on offering$5.2M2018-05-02
    • Came back fast: 3 mo vs the ~14 mo sector norm.
    • Round 2.6× larger than the prior — scaling up.
    • 9 investors on this round.
  19. Follow-on offering$4.1M2018-05-02
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
    • 7 investors on this round.
  20. Follow-on offering$6.0M2018-08-10
    • Came back fast: 3 mo vs the ~14 mo sector norm.
    • Round 1.5× larger than the prior — scaling up.
    • 9 investors on this round.
  21. Follow-on offering$2.5M2018-08-10
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 2.4× smaller than the prior — bridge or down round.
    • 1 investor on this round.
  22. Follow-on offering$4.7M2018-08-10
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.9× larger than the prior — scaling up.
    • 5 investors on this round.
  23. Follow-on offering$12.2M2018-11-16
    • Came back fast: 3 mo vs the ~14 mo sector norm.
    • Round 2.6× larger than the prior — scaling up.
    • 26 investors on this round.
  24. Follow-on offering$8.3M2018-11-16
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.5× smaller than the prior — bridge or down round.
    • 15 investors on this round.
  25. Follow-on offering$3.3M2018-11-16
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 2.5× smaller than the prior — bridge or down round.
    • 9 investors on this round.
  26. Follow-on offering$9.8M2018-11-16
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 2.9× larger than the prior — scaling up.
    • 19 investors on this round.
  27. Follow-on offering$6.3M2018-11-16
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.5× smaller than the prior — bridge or down round.
    • 10 investors on this round.
  28. Follow-on offering$16.2M2018-11-16
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 2.6× larger than the prior — scaling up.
    • 31 investors on this round.
  29. Follow-on offering$1.0M2019-05-02
    • Came back fast: 5 mo vs the ~14 mo sector norm.
    • Round 16.2× smaller than the prior — bridge or down round.
    • 2 investors on this round.
  30. Follow-on offering$6.3M2019-05-02
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 6.3× larger than the prior — scaling up.
    • 8 investors on this round.
  31. Follow-on offering$1.3M2020-10-09
    • Raised 17 mo later, in step with the ~14 mo sector norm.
    • Round 4.8× smaller than the prior — bridge or down round.
    • 5 investors on this round.
  32. Follow-on offering$6.5M2020-10-15
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 5.0× larger than the prior — scaling up.
    • 1 investor on this round.
  33. Follow-on offering$1.5M2020-10-30
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 4.3× smaller than the prior — bridge or down round.
    • 1 investor on this round.
Intelligence
2021 ~Q1
Modeled next raise · ~4mo cadence
$1.5M
Modeled next size est.range $1.5M$2.4M
0.2×
Last step-up
$10.9M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
CHRISTOPHER C DEWEY3 other2010-07
David Matlin3 other2018-11
EITAN MACHOVER3 other2010-07
IVAN DELEVIC2 other2014-11
Steven B. Epstein2 other2013-03
Michael Stansky1 other2013-03
Roman Bensen1 other2018-11
Chang Kyu Kim2017-04
Charles B. O'Meara2013-03
CHARLES C O'MEARA2010-12
Chris Kyu Dewey2019-05
David B. Matlin2013-03
DAVID C MATLIN2010-12
FLOYD C LOOP2010-12
Floyd D. Loop, M.D.2013-03
Ivan B. Delevic2015-11
Ivan Charles Delevic2016-04
JAY PIERCE2010-07
John Kyu Leo2018-01
John Kyu Mastrototaro2018-11
Jonathan B. Trousdale2018-08
Jonathan Charles Trousdale2016-04
Jonathan Trousdale2018-11
Lalitendu Kyu Panda2017-04
Registry & provenance

Orthosensor, Inc is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1436914
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Dermasensor, Inc.Other Health CareSeries A$29.2M$37.6Mnetwork2 shared operators · same sector
CareView Communications IncOther Health CareSeries B$51.0M$2.7Mnetwork1 shared operator · same sector · same stage
Radom CorpOther TechnologySeries A$7.7M$2.6Mnetwork3 shared operators
TriSalus Life Sciences, Inc.Other Health CareSeries C$209.1M$145.1Mnetwork1 shared operator · same sector
Palmaz Scientific IncOther Health CareSeries B$75.0M$29.1Msame sector · same stage
Javara Inc.Other Health CareSeries B$59.7M$33.2Msame sector · same stage
WellSense, Inc.Other Health CareSeries A$31.8M$31.0Mnetwork1 shared operator · same sector
Spinal Kinetics IncOther Health CareSeries B$53.7M$28.4Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Orthoevidence Inc.Other Health CarePre-Seed$30.8M89%
Orthobrain, Inc.Other Health CareSeries A$112.5M87%
ALM Ortho IncOther Health CarePre-Seed$579K87%
OrthoPreserve, Inc.Other Health CarePre-Seed$327K85%
Orthalign IncOther Health CareSeries B$237.3M84%
Adaptable Ortho Innovations LLCOther Health CarePre-Seed$7.4M84%
Orametrix IncOther Health CareSeries A$41.7M84%
Orca BioSystems IncOther Health CareSeries D+$4.4B84%
Frequently asked
How much funding has Orthosensor, Inc raised?
Orthosensor, Inc has raised approximately $112.8M in disclosed capital across 15 recorded financing rounds, aggregated from public filings.
What is Orthosensor, Inc's estimated valuation?
Provath's modeled valuation for Orthosensor, Inc is approximately $30.0M (modeled range $3.5M–$108.6M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Orthosensor, Inc at?
Orthosensor, Inc shows a recurring offering pattern rather than a clean VC stage progression. Its most recent recorded round closed around Fri Oct 30.
What does Orthosensor, Inc do and where is it based?
Orthosensor, Inc operates in the Other Health Care sector, based in DANIA BEACH.
Explore related

See where Orthosensor, Inc sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Orthosensor, Inc, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.